Wize Pharma, Inc. Bonus & Incentive Agreements
11 Contracts & Agreements
- Companys 2024 Omnibus Equity Incentive Plan (Filed With SEC on August 19, 2024)
- Form Of Stock Option Grant Notice And Option Agreement Under Companys 2024 Omnibus Equity Incentive Plan (Filed With SEC on August 19, 2024)
- 2021 Equity Incentive Plan (Filed With SEC on March 23, 2023)
- Addendum Agreement, between Wize Pharma, Inc. and Bonus BioGroup Ltd., dated November 29, 2020 (Filed With SEC on November 30, 2020)
- Amendment to Letter Agreement (SPA), dated July 1, 2020, by and between the Company and Bonus BioGroup Ltd (Filed With SEC on August 14, 2020)
- Letter Agreement (SPA), dated June 24, 2020, by and between the Company and Bonus BioGroup Ltd (Filed With SEC on August 14, 2020)
- Share Purchase Agreement by and between Bonus BioGroup Ltd. and Wize Pharma Inc., dated January 9, 2020 (Filed With SEC on January 15, 2020)
- Exchange Agreement by and between Bonus BioGroup Ltd. and Wize Pharma Inc., dated January 9, 2020 (Filed With SEC on January 15, 2020)
- Amendment to 2018 Equity Incentive Plan (Filed With SEC on August 21, 2018)
- 2018 Stock Incentive Plan (Filed With SEC on February 28, 2018)
- Exhibit 4.1 OPHTHALIX INC. 2012 STOCK INCENTIVE PLAN (Filed With SEC on February 9, 2012)
